Importance of eculizumab treatment in recurrence of atypical hemolytic uremic syndrome during the SARS-CoV-2 pandemic

Authors :: Oyku Ozgur
Erhan Tatar
Zuleyha Can Erdi
Anil Taşdemir
Bengü Tatar
Source :: International Urology and Nephrology
Publication Year :: 2021
Publisher :: Springer Science and Business Media LLC, 2021.

Subjects :: Nephrology
medicine.medical_specialty
2019-20 coronavirus outbreak
Coronavirus disease 2019 (COVID-19)
business.industry
Urology
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
Eculizumab
medicine.disease
Virology
Nephrology - Letter to the Editor
Internal medicine
Atypical hemolytic uremic syndrome
Pandemic
medicine
business
medicine.drug

Tools